Fig. 4From: A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients – Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC)LoQ for the Methylation assay. The limit of quantification (LoQ) for the QM-MSPCR1 (a) and QM-MSPCR2 (b) was determined by carrying out a series of dilutions with bisulfite converted DNA quantities of 10, 1, 0.1 and 0.01 ngBack to article page